ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
The rebound has been notable, with the stock climbing sharply from its Nov. 7, 2025, low of $13.76. Image Source: Zacks Investment Research The rally has been driven by the robust demand for Asceniv and a constructive outlook for 2026. ADMA Biologics develops and commercializes plasma-derived biologics for the treatment of immune deficiencies and the prevention of select infectious diseases. Against this backdrop, a closer examination of ADMA's key strengths and potential challenges is warranted to assess the stock's investment appeal. ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. The company's top line currently comprises sales of three FDA-approved products — Bivigam (an Intravenous Immune Globulin [“IVIG”] product to treat primary humoral immunodeficiency), Asceniv (to treat primary immunodeficiency disease or PIDD) and Nabi-HB (to treat and provide enhanced immunity against the
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics: Business Update And My Price Target [Seeking Alpha]Seeking Alpha
- How ADMA's Multi-Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Is ADMA Biologics (ADMA) Still Attractive After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
ADMA
Earnings
- 11/5/25 - Miss
ADMA
Sec Filings
- 1/12/26 - Form 8-K
- 12/16/25 - Form 4
- 11/21/25 - Form 4
- ADMA's page on the SEC website